PEC12-25 CAPEC-PROCESS Industrial Consortium ... - DTU Orbit

Preface
This report provides an overview of our research activities and achievements for the
period June 2011 to June 2012. An overview of the active research projects is provided in
terms of PhD-projects, post-doctoral and other research projects. A brief overview of the
CAPEC-PROCESS software is also included in this report.
While CAPEC and PROCESS remain as independent centers, research results from both
of the two centers are made available to the member companies of the consortium. In this
way, the consortium members get access to a larger number of MSc- and PhD-projects as
well as post-docs than before.
During the last 12-months, a number of PhD-projects have been successfully completed,
while an equal number of new projects have been started. More specifically, within
CAPEC: Carlos Axel Diaz-Tovar (PEC11-23) and Martina Heitzig (PEC12-24); within
PROCESS: Yuan Xu, Bodil Voss and Mads Orla Albæk; and jointly within CAPEC-
PROCESS: Alicia Roman-Martinez (PEC11-24); and PROCESS-CAPEC: Linfeng Yuan
(PEC11-45); Wenjing Fu (PEC11-46); Philip Lutze (PEC12-22), Albert Emil Cervera
Padrell (PEC12-23) and Paloma Santacoloma have all successfully defended their PhDtheses.
At the same time, new PhD-students (Hemalata Ramesh, Marie Andersson, Laura
Snip, Jason Price, Deenesh K. Babi, Hande Bozkurt, Larissa P Cunico, Peam Cheali and
Marina Fedorova) have started their PhD-projects at CAPEC and PROCESS centers
while 1 new post-doctoral project was also started (Albert Cervera-Padrell).
Collaborations with our member companies continue to help us to apply our research
results to interesting industrial problems, to get valuable feedback on our methods & tools
and to plan our future projects. Collaborations with our friends from academia help us to
develop more comprehensive CAPE/PSE methodologies and techniques. We appreciate
these collaborations and we thank our industrial and academic partners for their valuable
contributions. During the last 12-months, we have started projects with AstraZeneca,
Syngenta and Alfa-Laval from our consortium members, and, Univ of Lorraine (France),
Chulalongkorn Univ-PPC (Thailand), PROSPECT-UTM (Malaysia), Univ of Kansas
(USA), Univ of West Virginia (USA) and Auburn Univ (USA) from academia.
We would like to acknowledge the financial support in the form of membership fees from
our member companies. We would like to welcome Pfizer Inc (USA) and Janssen
Pharmaceutika N V (Belgium) as new consortium members. For funding of PhD and
post-doctoral research projects we would like to thank the Danish funding agencies FTP,
EFP and ATV and the EC-research programs under FP7. Also, we would like to thank the
governments of Malaysia, Brasil and Mexico for sending students with PhD/MScscholarships.
Finally, we take this opportunity to thank all co-workers of CAPEC and PROCESS for
their hard work and dedication. The research results highlighted in this report are their
achievements. This is the 15th year since CAPEC and the industrial consortium was
established. At PROCESS Ulrich Kruhne was promoted to Senior Researcher and Mrs.
Gitte Nielsen joined as a secretary.
2